Printer Friendly

SIGA Technologies Inc announces new Request for Proposal for 1.7m courses of smallpox antiviral.

M2 EQUITYBITES-February 22, 2011-SIGA Technologies Inc announces new Request for Proposal for 1.7m courses of smallpox antiviral(C)2011 M2 COMMUNICATIONS http://www.m2.com

Pharmaceutical agents supplier SIGA Technologies Inc (Nasdaq:SIGA) said on Monday that it has received a new Request for Proposal, number 11-100 -SOL-00007, seeking to procure 1.7m courses of a smallpox antiviral.

This Request for Proposal has been committed by the Biomedical Advanced Research and Development Authority (BARDA), a unit of the US Department of Health and Human Services.

The company added the Request for Proposal also covers an option to procure up to 12m additional courses as part of the proposed deal.

In addition, the company said it plans to respond to BARDA'S new Request for Proposal on 28 February 2011.

((Comments on this story may be sent to info@m2.com)).END.PUB430>PDFebruary 22, 2011>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Feb 22, 2011
Words:150
Previous Article:Chesapeake Energy Corporation disposes USD4.75bn Fayetteville Shale assets.
Next Article:Westlake Chemical Corp board reports dividend payout of USD0.0635 per share.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters